Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
Study Finds All Major Pharmaceutical Companies Implicated in Bribery Schemes
A study published in February 2026 in the Journal of Law, Medicine & Ethics is the first to compile decades of Organization for Economic Cooperation and Development (OECD) enforcement records into a single analysis. Researchers Kohler, Khan, and Bowra reviewed OECD Working Group on Bribery reports from 1999 through early 2025 and found that virtually […]
Australia Adds New Mental Health Risks to Ozempic and Other Rapid Weight Loss Drugs
The government of Australia has added two new safety warnings about mental health and contraception for the popular GLP-1 agonist drugs like Ozempic designed to facilitate rapid weight loss. The Therapeutic Goods Administration (TGA), which regulates pharmaceutical products for Australia, issued the new safety warnings in December.1 Health professionals say that, while there is no […]
Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]
FDA Plans for Expedited Licensure Approval of GSK’s Autism Drug
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA), in collaboration with the British pharmaceutical company GSK plc, announced plans to fast-track licensure of leucovorin calcium tablets. The drug, which GSK calls Wellcovorin, has long been used to treat anemia and counteract the effects of chemotherapy, The FDA will approve it for use […]
Johnson & Johnson Liable for Nearly $1 Billion in Damages for Cancer-Causing Baby Powder
Earlier this month, a jury in Los Angeles, found Johnson & Johnson, Inc. (J&J) was liable for damages in the amount of $966 million dollars to the family of a long-time consumer of its baby talcum powder. The jury concluded that the pharmaceutical giant was liable for its dangerous talcum powder product which caused the […]